Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators

Conclusions
Although no single mediator may account for this effect, serum shortly post-OLT enhances HCV infection. FGF-2 is a novel endogenous driver of HCV replication and a potential therapeutic target.

Source: Gut - May 9, 2016 Category: Gastroenterology Authors: Van, N. D., Falk, C. S., Sandmann, L., Vondran, F. W. R., Helfritz, F., Wedemeyer, H., Manns, M. P., Ciesek, S., von Hahn, T. Tags: Open access Hepatology Source Type: research